WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that it has strengthened its alliance with PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider. The multi-year agreement allows PAREXEL to continue to offer Phase Forward’s InForm™ electronic data capture (EDC) product as an integral part of its solution set.
